AIA
IBB icon

Ally Invest Advisors’s iShares Biotechnology ETF IBB Stock Holding History

Ally Invest Advisors’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$282K Sell
1,671
-91
-5% -$15.6K 0.02% 70
2025
Q4 		$297K Sell
1,762
-228
-11% -$37K 0.02% 69
2025
Q3 		$287K Buy
1,990
+52
+3% +$7.1K 0.02% 67
2025
Q2 		$245K Buy
1,938
+338
+21% +$41.5K 0.02% 71
2025
Q1 		$205K Buy
1,600
+85
+6% +$11.5K 0.02% 70
2024
Q4 		$200K Buy
1,515
+76
+5% +$10.7K 0.02% 67
2024
Q3 		$210K Buy
+1,439
New +$208K 0.02% 67

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Ally Invest Advisors's IBB Position: Q1 2026 in Review

Ally Invest Advisors reduced its iShares Biotechnology ETF (IBB) stake by 5.2% in Q1 2026, selling an estimated $15.6K and leaving 1,671 shares worth $282K. The position accounts for 0.02% of the portfolio, ranked #70.

Ally Invest Advisors first reported a position in IBB in Q3 2024 and has held it in 7 quarters since. The position peaked at $297K in Q4 2025. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

  • Ally Invest Advisors held 1,671 shares of iShares Biotechnology ETF worth $282K as of Q1 2026.
  • Ally Invest Advisors sold 91 iShares Biotechnology ETF shares in Q1 2026, an estimated $15.6K.
  • iShares Biotechnology ETF made up 0.02% of Ally Invest Advisors's portfolio in Q1 2026, its #70 holding.
  • Ally Invest Advisors first reported a position in iShares Biotechnology ETF in Q3 2024 and has held it in 7 quarters since.
  • Ally Invest Advisors's iShares Biotechnology ETF position peaked at $297K in Q4 2025.
  • 917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on Ally Invest Advisors's 13F filing for Q1 2026, filed 12 May 2026.